An Open-label Therapeutic Efficacy Study of Tirosint (Levothyroxine Sodium) Capsules in Thyroidectomized Patients Taking Proton Pump Inhibitors
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2017
At a glance
- Drugs Levothyroxine sodium (Primary)
- Indications Hypothyroidism
- Focus Therapeutic Use
- Sponsors IBSA
- 16 Jun 2017 Status changed from not yet recruiting to recruiting.
- 07 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 Apr 2017.
- 31 Mar 2017 New trial record